The U.S. Food and Drug Administration (FDA) has approved emergency use of a rapid at-home COVID-19 test kit.
The single-use test, made by Lucira Health, has been given emergency use authorization for home use with self-collected nasal swab samples in individuals age 14 and older who are suspected of COVID-19 by their health care provider, the FDA said.
“While COVID-19 diagnostic tests have been authorized for at-home collection, this is the first that can be fully self-administered and provide results at home,” FDA Commissioner Stephen Hahn said.
It requires a prescription, but it provides results in roughly 30 minutes.
David Akin looks at whether a similar test could be coming to Canada soon.
For more info, please go to https://globalnews.ca/news/7469300/coronavirus-at-home-test/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews
The single-use test, made by Lucira Health, has been given emergency use authorization for home use with self-collected nasal swab samples in individuals age 14 and older who are suspected of COVID-19 by their health care provider, the FDA said.
“While COVID-19 diagnostic tests have been authorized for at-home collection, this is the first that can be fully self-administered and provide results at home,” FDA Commissioner Stephen Hahn said.
It requires a prescription, but it provides results in roughly 30 minutes.
David Akin looks at whether a similar test could be coming to Canada soon.
For more info, please go to https://globalnews.ca/news/7469300/coronavirus-at-home-test/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews
- Category
- U.S. & Canada
- Tags
- coronavirus, COVID-19, corona virus
Sign in or sign up to post comments.
Be the first to comment